{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:27:15Z","timestamp":1772195235191,"version":"3.50.1"},"reference-count":20,"publisher":"Hindawi Limited","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Oncology"],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:p><jats:italic>Background\/Aims<\/jats:italic>. To report the safety and efficacy of strontium (Sr<jats:sup>90<\/jats:sup>) beta radiotherapy as adjuvant treatment for conjunctival melanoma.<jats:italic>Methods<\/jats:italic>. A retrospective cohort study was undertaken from 1999 to 2007 of all patients who underwent Sr<jats:sup>90<\/jats:sup>beta radiotherapy for incompletely excised conjunctival melanoma. Failure of treatment was defined as recurrence of a conjunctival melanoma at the same location following beta radiotherapy.<jats:italic>Results<\/jats:italic>. Twenty patients underwent Sr<jats:sup>90<\/jats:sup>beta radiotherapy for incompletely excised conjunctival melanoma. Median follow-up interval was 59 months (8\u2013152). All patients had conjunctival melanoma involving the bulbar conjunctiva. Underlying diagnoses included PAM with atypia in 60% (12 of 20), PAM without atypia in 15% (3 of 20), and de novo conjunctival melanoma in 25% (5 of 20). Following Sr<jats:sup>90<\/jats:sup>beta radiotherapy, in 90% (18 out of 20) local control was achieved and visual acuity was not affected in any patient. Three patients (15%) had dry eye symptoms, episcleritis, and descemetcoele, respectively. No cataract or secondary glaucoma was reported.<jats:italic>Conclusions<\/jats:italic>. Sr<jats:sup>90<\/jats:sup>treatment is a very effective adjuvant treatment after excisional biopsy and cryotherapy for conjunctival melanoma with a local success rate of 90%. The treatment is not associated with significant side effects and visual acuity is not affected.<\/jats:p>","DOI":"10.1155\/2013\/349162","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T16:01:23Z","timestamp":1359648083000},"page":"1-7","source":"Crossref","is-referenced-by-count":34,"title":["The Use of Strontium-90 Beta Radiotherapy as Adjuvant Treatment for Conjunctival Melanoma"],"prefix":"10.1155","volume":"2013","author":[{"given":"Victoria M. L.","family":"Cohen","sequence":"first","affiliation":[{"name":"Ocular Oncology Service, St Bartholomew\u2019s Hospital and Moorfields Eye Hospital, West Smithfield, London EC1A 7BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios P.","family":"Papastefanou","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, St Bartholomew\u2019s Hospital and Moorfields Eye Hospital, West Smithfield, London EC1A 7BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Liu","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, St Bartholomew\u2019s Hospital and Moorfields Eye Hospital, West Smithfield, London EC1A 7BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Stoker","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, St Bartholomew\u2019s Hospital, London EC1A 7BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Hungerford","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, St Bartholomew\u2019s Hospital and Moorfields Eye Hospital, West Smithfield, London EC1A 7BE, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.154"},{"issue":"11","key":"2","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","volume":"118","year":"2000","journal-title":"Archives of Ophthalmology"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.06.021"},{"issue":"8","key":"4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0161-6420(88)33058-7","volume":"95","year":"1988","journal-title":"Ophthalmology"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.060"},{"issue":"3","key":"6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000310419","volume":"207","year":"1993","journal-title":"Ophthalmologica"},{"issue":"12","key":"7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1055\/s-0028-1109651","volume":"226","year":"2009","journal-title":"Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1097\/01.IOP.0000056020.66654.33"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-0093-5"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-009-1189-0"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700306"},{"key":"12","volume-title":"Uveal melanoma 591-610","year":"2012"},{"issue":"3","key":"13","first-page":"378","volume":"97","year":"1977","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"issue":"2","key":"14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00407844","volume":"209","year":"1978","journal-title":"Albrecht von Graefe's Archive for Clinical and Experimental Ophthalmology"},{"issue":"7","key":"15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-2008-1027432","volume":"225","year":"2008","journal-title":"Klinische Monatsbl\u00e4tter f\u00fcr Augenheilkunde"},{"key":"16","volume":"89, article s248","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.086850"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.176099"},{"issue":"5","key":"20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/bjo.82.5.476","volume":"82","year":"1998","journal-title":"British Journal of Ophthalmology"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-006-1341-8"}],"container-title":["Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2013\/349162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2013\/349162.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/jo\/2013\/349162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T02:47:07Z","timestamp":1498013227000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.hindawi.com\/journals\/jo\/2013\/349162\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":20,"alternative-id":["349162","349162"],"URL":"https:\/\/doi.org\/10.1155\/2013\/349162","relation":{},"ISSN":["1687-8450","1687-8469"],"issn-type":[{"value":"1687-8450","type":"print"},{"value":"1687-8469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}